FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

I Hosokawa

Research Profile

Anatomy

Chemicals & Drugs

Procedures

Reverse Transcriptase Polymerase Chain Reaction

Physiology

Signal Transduction

Disorders

Co-author Network

Publications

TOP 3
Yoshitaka Hosokawa; Hideaki Nakae; Kazumi Ozaki; Satoru Shindo; I Hosokawa; Takashi Matsuo
Tumor necrosis factor-like weak inducer of apoptosis increases CC chemokine ligand 20 production in interleukin 1β-stimulated human gingival fibroblasts.
Yoshitaka Hosokawa; I Hosokawa; Satoru Shindo; Kazumi Ozaki; Tadashi Nakanishi; Hideaki Nakae; Takashi Matsuo
Black tea polyphenol inhibits CXCL10 production in oncostatin M-stimulated human gingival fibroblasts.
Yoshitaka Hosokawa; I Hosokawa; Kazumi Ozaki; Hideaki Nakae; Takashi Matsuo
Oncostatin M synergistically induces CXCL10 and ICAM-1 expression in IL-1beta-stimulated-human gingival fibroblasts.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of I Hosokawa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Yoshitaka Hosokawa; Hideaki Nakae; Kazumi Ozaki; Satoru Shindo; I Hosokawa; Takashi Matsuo
Tumor necrosis factor-like weak inducer of apoptosis increases CC chemokine ligand 20 production in interleukin 1β-stimulated human gingival fibroblasts.
Human immunology 2012;73(5):470-3.
2011: Yoshitaka Hosokawa; I Hosokawa; Satoru Shindo; Kazumi Ozaki; Tadashi Nakanishi; Hideaki Nakae; Takashi Matsuo
Black tea polyphenol inhibits CXCL10 production in oncostatin M-stimulated human gingival fibroblasts.
International immunopharmacology 2011;11(6):670-4.
2010: Yoshitaka Hosokawa; I Hosokawa; Kazumi Ozaki; Hideaki Nakae; Takashi Matsuo
Oncostatin M synergistically induces CXCL10 and ICAM-1 expression in IL-1beta-stimulated-human gingival fibroblasts.
Journal of cellular biochemistry 2010;111(1):40-8.
2010: Yoshitaka Hosokawa; I Hosokawa; Kazumi Ozaki; Tadashi Nakanishi; Hideaki Nakae; Takashi Matsuo
Tea polyphenols inhibit IL-6 production in tumor necrosis factor superfamily 14-stimulated human gingival fibroblasts.
Molecular nutrition & food research 2010;54 Suppl 2():S151-8.
2010: Yoshitaka Hosokawa; I Hosokawa; Kazumi Ozaki; Tadashi Nakanishi; Hideaki Nakae; Takashi Matsuo
Catechins inhibit CXCL10 production from oncostatin M-stimulated human gingival fibroblasts.
The Journal of nutritional biochemistry 2010;21(7):659-64.
2010: I Hosokawa; Yoshitaka Hosokawa; Kazumi Ozaki; Hiromichi Yumoto; Hideaki Nakae; Toshihiko Matsuo
Proinflammatory effects of muramyldipeptide on human gingival fibroblasts.
Journal of periodontal research 2010;45(2):193-9.
2010: Yoshitaka Hosokawa; I Hosokawa; Kazumi Ozaki; Hideaki Nakae; Takashi Matsuo
TNFSF14 coordinately enhances CXCL10 and CXCL11 productions from IFN-gamma-stimulated human gingival fibroblasts.
Molecular immunology 2010;47(4):666-70.
2009: Yoshitaka Hosokawa; I Hosokawa; Kazumi Ozaki; Hideaki Nakae; Toshihiko Matsuo
Human gingival fibroblasts express functional chemokine receptor CXCR6.
Clinical and experimental immunology 2009;156(3):413-8.
2009: Yoshitaka Hosokawa; I Hosokawa; Kazumi Ozaki; Hideaki Nakae; Toshihiko Matsuo
Cytokines differentially regulate CXCL10 production by interferon-gamma-stimulated or tumor necrosis factor-alpha-stimulated human gingival fibroblasts.
Journal of periodontal research 2009;44(2):225-31.
2009: Yoshitaka Hosokawa; I Hosokawa; Kazumi Ozaki; Tadashi Nakanishi; Hideaki Nakae; Takashi Matsuo
Catechins inhibit CCL20 production in IL-17A-stimulated human gingival fibroblasts.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009;24(5-6):391-6.
2008: Yoshitaka Hosokawa; I Hosokawa; Kazumi Ozaki; Hideaki Nakae; Takashi Matsuo
CC chemokine ligand 17 in periodontal diseases: expression in diseased tissues and production by human gingival fibroblasts.
Journal of periodontal research 2008;43(4):471-7.
2008: I Hosokawa; Yoshitaka Hosokawa; Kazumi Ozaki; Hideaki Nakae; Takashi Matsuo
Adrenomedullin suppresses tumour necrosis factor alpha-induced CXC chemokine ligand 10 production by human gingival fibroblasts.
Clinical and experimental immunology 2008;152(3):568-75.
2007: Yoshitaka Hosokawa; I Hosokawa; Kazumi Ozaki; Hideaki Nakae; Takashi Matsuo
CXC chemokine ligand 16 in periodontal diseases: expression in diseased tissues and production by cytokine-stimulated human gingival fibroblasts.
Clinical and experimental immunology 2007;149(1):146-54.
2006: Yoshitaka Hosokawa; I Hosokawa; Kazumi Ozaki; Hideaki Nakae; Takashi Matsuo
Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts.
Clinical and experimental immunology 2006;146(3):540-9.
2006: Yoshitaka Hosokawa; I Hosokawa; Kazumi Ozaki; Hideaki Nakae; Takashi Matsuo
Cytokines differentially regulate ICAM-1 and VCAM-1 expression on human gingival fibroblasts.
Clinical and experimental immunology 2006;144(3):494-502.
2005: Yoshitaka Hosokawa; I Hosokawa; Kazumi Ozaki; Hideaki Nakae; Takashi Matsuo
Increase of CCL20 expression by human gingival fibroblasts upon stimulation with cytokines and bacterial endotoxin.
Clinical and experimental immunology 2005;142(2):285-91.
2005: Yoshitaka Hosokawa; I Hosokawa; Kazumi Ozaki; Hideaki Nakae; K Murakami; Y Miyake; Takashi Matsuo
CXCL12 and CXCR4 expression by human gingival fibroblasts in periodontal disease.
Clinical and experimental immunology 2005;141(3):467-74.